A close look at fenfluramine and dexfenfluramine (Q41738934)

8 October 2017

1 reference

title

A close look at fenfluramine and dexfenfluramine (English)

1 reference

8 October 2017

Vivero LE

1 reference

8 October 2017

Anderson PO

series ordinal

1 reference

8 October 2017

Clark RF

series ordinal

1 reference

8 October 2017

publication date

1 March 1998

1 reference

Journal of Emergency Medicine

8 October 2017

published in

1 reference

8 October 2017

1 reference

8 October 2017

1 reference

8 October 2017

page(s)

197-205

1 reference

Medical hazards of obesity

8 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Body Weight and Mortality among Women

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Long-term weight control study. I (weeks 0 to 34). The enhancement of behavior modification, caloric restriction, and exercise by fenfluramine plus phentermine versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Long-term weight control study. II (weeks 34 to 104). An open-label study of continuous fenfluramine plus phentermine versus targeted intermittent medication as adjuncts to behavior modification, caloric restriction, and exercise

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Long-term weight control study. III (weeks 104 to 156). An open-label study of dose adjustment of fenfluramine and phentermine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Long-term weight control study. IV (weeks 156 to 190). The second double-blind phase

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Long-term weight control study. V (weeks 190 to 210). Follow-up of participants after cessation of medication

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Long-term weight control study. VI. Individual participant response patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Long-term weight control study. VII (weeks 0 to 210). Serum lipid changes

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Effect of fenfluramine on blood-lipids in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Effects of the l isomer of fenfluramine on dopamine mechanisms in rat brain: further studies

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

CARDIOVASCULAR AND AUTONOMIC EFFECTS OF FENFLURAMINE HYDROCHLORIDE

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

EEG profiles of fenfluramine, amobarbital and dextroamphetamine in normal volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Fenfluramine in obese patients on various antihypertensive drugs. Double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

International trial of long-term dexfenfluramine in obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Dexfenfluramine in the treatment of severe obesity: a placebo-controlled investigation of the effects on weight loss, cardiovascular risk factors, food intake and eating behaviour

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Withdrawal Depression in Obese Patients after Fenfluramine Treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Fenfluramine in the treatment of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Possible association of pulmonary hypertension with an anorectic drug

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

A case of drug-induced (?) pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Appetite-suppressant drugs and the risk of primary pulmonary hypertension. International Primary Pulmonary Hypertension Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Appetite suppressants and primary pulmonary hypertension in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Increased plasma serotonin in primary pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Primary pulmonary hypertension and fenfluramine use

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Pathology of pulmonary hypertension: a human and experimental study.

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Pulmonary hypertension and dexfenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Pulmonary hypertension and fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Further cases of valvular heart disease associated with fenfluramine-phentermine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Valvular heart disease associated with fenfluramine-phentermine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Fenfluramine overdosage

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Fenfluramine poisoning

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Diazepam for fenfluramine intoxication

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Drugs of Dependence Though Not of Abuse: Fenfluramine and Imipramine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Chronic fenfluramine administration: some cerebral effects

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

Unusual effect of fenfluramine

1 reference

https://api.crossref.org/works/10.1016%2FS0736-4679%2897%2900289-8

7 January 2021

10.1016/S0736-4679(97)00289-8

Identifiers

DOI

1 reference

8 October 2017

1 reference